A Sensitive and Optimized HPLC-FLD Method for the Simultaneous Quantification of Hydroxychloroquine and Its Two Metabolites in Blood of Systemic Lupus Erythematosus Patients
- 1 August 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 58 (7), 600-605
- https://doi.org/10.1093/chromsci/bmaa023
Abstract
Quantification of hydroxychloroquine (HCQ) and its two metabolites desethylchloroquine and desethylhydroxychloroquine in human blood can provide insight into the pharmacokinetic/pharmacodynamic characteristics of HCQ for the treatment of systemic lupus erythematosus (SLE), which is crucial for the optimization of the therapy. A simple, sensitive and optimized high performance liquid chromatography with fluorescence detection method has been developed and validated for the simultaneous determination of HCQ and its two metabolites in human blood. After addition of internal standard chloroquine, the blood sample was deproteinized with 2-fold acetonitrile and separated on an YMC-Triart C18 column (250x4.6 mm, 5 mu m) with a mobile phase of 20mM sodium phosphate buffer solution containing 0.25% triethylamine (pH 8.0)-acetonitrile (60:40, v/v). The analytes were detected by using fluorescence detection at an excitation and emission wavelength of 337 and 405 nm, respectively. The method was linear over the range of 3-3000 ng/mL for all three analytes and the chromatographic run timewas 9 min. The values for intra- and inter-day precisions were ranged from 1.3 to 7.3. This method was successfully applied to quantify the concentrations of HCQ and its two metabolites in blood of 92 SLE patients.Funding Information
- JiangSu Pharmaceutical Association and Chia Tai Tianqing (Q2019042)
This publication has 19 references indexed in Scilit:
- Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus ErythematosusArthritis Care & Research, 2016
- The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus ErythematosusThe Journal of Rheumatology, 2013
- The role of antimalarial agents in the treatment of SLE and lupus nephritisNature Reviews Nephrology, 2011
- Clinical and Pharmacogenetic Influences on Response to Hydroxychloroquine in Discoid Lupus Erythematosus: A Retrospective Cohort StudyJournal of Investigative Dermatology, 2011
- Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohortAnnals Of The Rheumatic Diseases, 2008
- Previous antimalarial therapy in patients diagnosed with lupus nephritis: Influence on outcomes and survivalLupus, 2008
- Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosusLupus, 2007
- Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosusLupus, 2006
- Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritisArthritis & Rheumatism, 2002
- Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritisArthritis & Rheumatism, 1987